Skip to main content

BioTechniques is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Journal
    • Aims and scope
    • Current Volume
    • Editorial board
    • For authors
    • Your editors: what do we do?

    Follow us on social media

  • News
    • Latest news
    • Tech news
    • Events news
    • Company news

    Follow us on social media

  • Multimedia
    • Downloadable eBooks
    • Infographics
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • Features
    • Interviews
    • Opinion
    • In Focus
    • Spotlights
    • Partners
    • New products
    • Events

    Follow us on social media

  • Topics
    • Analytical chemistry
      • Biochemistry
      • Bioengineering and biophysics
      • Cancer research
      • Careers and Publishing
      • Cell and tissue biology
      • COVID-19
      • CRISPR
      • Computational biology
    • Diagnostics and preclinical
      • Drug discovery and development
      • Imaging
      • Immunology
      • Lab design and machinery
      • Microbiology
      • Molecular biology
    • Nanomedicine
      • Neuroscience
      • PCR and sequencing
      • Plant and climate science
      • Proteomics
      • Veterinary science
      • Whole-genome studies

    Follow us on social media

  • Become a member
INFOGRAPHIC Integrating new approach methodologies into your therapeutics development research DOWNLOAD NOW!

March 2022 – Vol. 72 No. 3

Submit to journal

List of Contents

March 2022 ‐ Vol. 72 No. 3

Technology News

Has DeepMind's AlphaFold solved the protein folding problem?

Expert Opinions

Smart PCR machines can reduce the risk of carryover contamination

Letter to the Editor

Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13

Reports

Effective strategies for isolating DNA from members of Asteraceae with high concentrations of secondary metabolites

Reports

Fast assay to predict multipotent mesenchymal stromal cell replicative senescence dynamics

Benchmarks

Reliable budding pattern classification of yeast cells with time-resolved measurement of metabolite production

Benchmarks

Comparison of optimized methodologies for isolating nuclei from esophageal tissue

  • About BioTechniques
  • Advisory Board
  • Contact Us
  • Advertising
  • Permissions
  • Whitelist Emails
  • Press release policy
  • Accessibility
Contact
Contact Us
Office info

BioTechniques is powered by Taylor & Francis Group

BioTechniques, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom

Impact Factor 2.2 | CiteScore 2.0

  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 BioTechniques